CIA
MEDP icon

Capital Impact Advisors’s Medpace MEDP Stock Holding History

Capital Impact Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.2M Buy
68,439
+54,309
+384% +$25.1M 2.03% 23
2026
Q1 		$6.79M Sell
14,130
-69,832
-83% -$35.8M 2.74% 20
2025
Q4 		$47.2M Buy
83,962
+56,967
+211% +$32.3M 3.69% 8
2025
Q3 		$13.9M Buy
26,995
+6,495
+32% +$2.84M 3.1% 15
2025
Q2 		$6.5M Buy
20,500
+374
+2% +$112K 1.96% 27
2025
Q1 		$6.13M Buy
+20,126
New +$6.77M 2.35% 26
2024
Q3 		– Sell
-1,754
Closed -$722K – 24
2024
Q2 		$722K Sell
1,754
-1,276
-42% -$505K 2.03% 19
2024
Q1 		$1.22M Hold
3,030
– – 1.59% 19
2023
Q4 		$929K Sell
3,030
-428
-12% -$116K 1.22% 32
2023
Q3 		$837K Buy
3,458
+1,117
+48% +$286K 1.4% 18
2023
Q2 		$562K Hold
2,341
– – 0.62% 71
2023
Q1 		$440K Buy
+2,341
New +$484K 0.54% 85
2022
Q1 		– Sell
-8,698
Closed -$1.89M – 196
2021
Q4 		$1.89M Hold
8,698
– – 1.31% 25
2021
Q3 		$1.65M Hold
8,698
– – 0.65% 66
2021
Q2 		$1.54M Sell
8,698
-9,000
-51% -$1.55M 0.5% 82
2021
Q1 		$2.9M Hold
17,698
– – 1.02% 43
2020
Q4 		$2.46M Hold
17,698
– – 0.61% 67
2020
Q3 		$1.98M Hold
17,698
– – 0.59% 81
2020
Q2 		$1.65M Sell
17,698
-12,136
-41% -$1.03M 0.55% 86
2020
Q1 		$2.19M Buy
29,834
+954
+3% +$82.8K 0.92% 41
2019
Q4 		$2.43M Buy
28,880
+2,045
+8% +$158K 0.85% 32
2019
Q3 		$2.23M Sell
26,835
-6,845
-20% -$517K 0.85% 34
2019
Q2 		$2.16M Buy
33,680
+835
+3% +$48.1K 0.79% 40
2019
Q1 		$1.7M Hold
32,845
– – 0.75% 53
2018
Q4 		$1.7M Sell
32,845
-6,926
-17% -$380K 0.73% 56
2018
Q3 		$2.36M Hold
39,771
– – 0.81% 41
2018
Q2 		$1.71M Hold
39,771
– – 0.63% 88
2018
Q1 		$1.39M Buy
+39,771
New +$1.45M 0.57% 91

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Impact Advisors's MEDP Position: Q2 2026 in Review

Capital Impact Advisors increased its Medpace (MEDP) stake by 384% in Q2 2026, buying an estimated $25.1M and bringing the position to 68,439 shares worth $36.2M. The position accounts for 2.03% of the portfolio, ranked #23.

Capital Impact Advisors first reported a position in MEDP in Q1 2018 and has held it in 28 quarters since. The position peaked at $47.2M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Capital Impact Advisors held 68,439 shares of Medpace worth $36.2M as of Q2 2026.
  • Capital Impact Advisors bought 54,309 Medpace shares in Q2 2026, an estimated $25.1M.
  • Medpace made up 2.03% of Capital Impact Advisors's portfolio in Q2 2026, its #23 holding.
  • Capital Impact Advisors first reported a position in Medpace in Q1 2018 and has held it in 28 quarters since.
  • Capital Impact Advisors's Medpace position peaked at $47.2M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Capital Impact Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.